Faculty of Medical Sciences, University of Kragujevac, and Clinic for Pulmonology, Clinical Centre, Kragujevac, Serbia.
Faculty of Medicine, University of Niš, and Clinic for Lung Diseases, Clinical Centre, Niš, Serbia.
Int J Chron Obstruct Pulmon Dis. 2021 Mar 16;16:643-654. doi: 10.2147/COPD.S300693. eCollection 2021.
Establishing a regional/national/international registry of patients suffering from chronic obstructive pulmonary disease (COPD) is essential for both research and healthcare, because it enables collection of comprehensive real-life data from a large number of individuals.
The aim of this study was to describe characteristics of COPD patients from the Serbian patient registry, and to investigate actual differences of those characteristics among the COPD phenotypes.
The Serbian registry of patients with COPD was established in 2018 at University of Kragujevac, Faculty of Medical Sciences, based on an online platform. Entry in the Registry was allowed for patients who were diagnosed with COPD according to the following criteria: symptoms of dyspnea, chronic cough or sputum production, history of risk factors for COPD and any degree of persistent airflow limitation diagnosed at spirometry.
In the Serbian COPD registry B and D GOLD group were dominant, while among the COPD phenotypes, the most prevalent were non-exacerbators (49.4%) and then frequent exacerbators without chronic bronchitis (29.6%). The frequent exacerbator with chronic bronchitis phenotype was associated with low levels of bronchopulmonary function and absolute predominance of GOLD D group. Anxiety, depression, insomnia, hypertension and chronic heart failure were the most prevalent in the frequent exacerbator with chronic bronchitis phenotype; patients with this phenotype were also treated more frequently than other patients with a triple combination of the most effective inhaled anti-obstructive drugs: long-acting muscarinic antagonists, long-acting beta 2 agonists and corticosteroids.
In conclusion, the data from the Serbian registry are in line with those from other national registries, showing that frequent exacerbators with chronic bronchitis have worse bronchopulmonary function, more severe signs and symptoms, and more comorbidities (especially anxiety and depression) than other phenotypes. Other studies also confirmed worse quality of life and worse prognosis of the AE-CB phenotype, stressing importance of both preventive and appropriate therapeutic measures against chronic bronchitis.
建立一个涵盖慢性阻塞性肺疾病(COPD)患者的区域/国家/国际登记处对于研究和医疗保健都至关重要,因为它可以从大量个体中收集全面的真实数据。
本研究旨在描述来自塞尔维亚 COPD 患者登记处的患者特征,并研究 COPD 表型之间这些特征的实际差异。
塞尔维亚 COPD 患者登记处于 2018 年在克拉古耶瓦茨大学医学科学学院建立,基于一个在线平台。符合以下标准的患者可以在登记处登记:呼吸困难、慢性咳嗽或咳痰症状、COPD 危险因素史以及肺量计诊断出任何程度的持续性气流受限。
在塞尔维亚 COPD 登记处,B 和 D GOLD 组占主导地位,而在 COPD 表型中,最常见的是非加重型(49.4%),然后是无慢性支气管炎的频繁加重型(29.6%)。具有慢性支气管炎表型的频繁加重型与较低的支气管肺功能水平和绝对占主导地位的 GOLD D 组相关。具有慢性支气管炎表型的频繁加重型患者焦虑、抑郁、失眠、高血压和慢性心力衰竭更为常见;与其他患者相比,该表型患者也更频繁地接受最有效的三联吸入性抗阻塞药物治疗:长效毒蕈碱拮抗剂、长效β2 激动剂和皮质类固醇。
总之,来自塞尔维亚登记处的数据与其他国家登记处的数据一致,表明具有慢性支气管炎的频繁加重型患者的支气管肺功能更差,症状和体征更严重,合并症更多(尤其是焦虑和抑郁)。其他研究还证实了 AE-CB 表型的生活质量更差和预后更差,强调了预防和适当的治疗措施对慢性支气管炎的重要性。